Boothbay Fund Management’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $838K | Sell |
10,000
-3,750
| -27% | -$314K | 0.02% | 578 |
|
|
2025
Q1 | $982K | Buy |
+13,750
| New | +$982K | 0.03% | 512 |
|
|
2024
Q4 | – | Sell |
-51,710
| Closed | -$2.61M | – | 1671 |
|
|
2024
Q3 | $2.61M | Sell |
51,710
-52,310
| -50% | -$2.64M | 0.06% | 359 |
|
|
2024
Q2 | $4.24M | Sell |
104,020
-28,011
| -21% | -$1.14M | 0.1% | 231 |
|
|
2024
Q1 | $5.65M | Buy |
132,031
+8,892
| +7% | +$381K | 0.11% | 160 |
|
|
2023
Q4 | $4.96M | Buy |
123,139
+14,762
| +14% | +$594K | 0.13% | 160 |
|
|
2023
Q3 | $3.2M | Buy |
+108,377
| New | +$3.2M | 0.08% | 289 |
|
|
2022
Q2 | – | Sell |
-16,810
| Closed | -$56K | – | 2277 |
|
|
2022
Q1 | $56K | Buy |
16,810
+16,000
| +1,975% | +$53.3K | ﹤0.01% | 1781 |
|
|
2021
Q4 | $5K | Hold |
810
| – | – | ﹤0.01% | 1641 |
|
|
2021
Q3 | $11K | Sell |
810
-51
| -6% | -$693 | ﹤0.01% | 1609 |
|
|
2021
Q2 | $15K | Hold |
861
| – | – | ﹤0.01% | 1634 |
|
|
2021
Q1 | $16K | Hold |
861
| – | – | ﹤0.01% | 1261 |
|
|
2020
Q4 | $25K | Buy |
+861
| New | +$25K | ﹤0.01% | 1034 |
|
|
2020
Q3 | – | Sell |
-2,832
| Closed | -$94K | – | 1084 |
|
|
2020
Q2 | $94K | Buy |
+2,832
| New | +$94K | 0.01% | 758 |
|